We are live on ! Find out more
AF

Avanza Fonder Portfolio holdings

AUM $4.59B
1-Year Est. Return 41.03%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+41.03%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.94B
AUM Growth
+$86.8M
Cap. Flow
-$15.7M
Cap. Flow %
-0.4%
Top 10 Hldgs %
39.36%
Holding
529
New
101
Increased
162
Reduced
70
Closed
32

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$82.7M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$35M
3
JPM icon
JPMorgan Chase
JPM
+$28.6M
4
LLY icon
Eli Lilly
LLY
+$27.6M
5
AXON
Axon Enterprise
AXON
+$11.5M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$153M
2
AAPL icon
Apple
AAPL
+$128M
3
AMZN icon
Amazon
AMZN
+$42.2M
4
TSLA icon
Tesla
TSLA
+$38.8M
5
GEV icon
GE Vernova
GEV
+$13.8M

Sector Composition

Rank Sector Weight
1 Technology 34.22%
2 Financials 14.23%
3 Consumer Discretionary 12.14%
4 Communication Services 11.6%
5 Healthcare 11.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOX icon
401
Fox Class B
FOX
$22.1B
$578K 0.01%
8,898
– –
NBIX icon
402
Neurocrine Biosciences
NBIX
$16.7B
$552K 0.01%
3,890
+149
+4% +$21.6K
TU icon
403
Telus
TU
$15B
$550K 0.01%
30,382
– –
ONC
404
BeOne Medicines Ltd
ONC
$32.6B
$428K 0.01%
1,408
+340
+32% +$111K
INTC icon
405
Intel
INTC
$459B
$388K 0.01%
+10,521
New +$397K
PCYO icon
406
Pure Cycle
PCYO
$258M
$369K 0.01%
33,571
-1,388
-4% -$15.5K
ON icon
407
ON Semiconductor
ON
$31.3B
$322K 0.01%
+5,942
New +$305K
BBIO icon
408
BridgeBio Pharma
BBIO
$15.7B
$319K 0.01%
4,168
-1,571
-27% -$103K
P
409
Everpure Inc
P
$26.6B
$316K 0.01%
+4,711
New +$394K
MSTR icon
410
Strategy Inc
MSTR
$34.7B
$312K 0.01%
+2,055
New +$473K
INCY icon
411
Incyte
INCY
$24B
$290K 0.01%
+2,935
New +$284K
IONS icon
412
Ionis Pharmaceuticals
IONS
$9.06B
$284K 0.01%
+3,596
New +$271K
HQY icon
413
HealthEquity
HQY
$8.72B
$282K 0.01%
3,078
-294
-9% -$28.1K
MMS icon
414
Maximus
MMS
$3.27B
$257K 0.01%
2,981
-252
-8% -$21.5K
KRYS icon
415
Krystal Biotech
KRYS
$9.21B
$246K 0.01%
996
-422
-30% -$88.8K
OSIS icon
416
OSI Systems
OSIS
$3.72B
$242K 0.01%
949
-102
-10% -$26.6K
RVMD icon
417
Revolution Medicines
RVMD
$38.8B
$242K 0.01%
3,036
-1,299
-30% -$85.2K
NAMS icon
418
NewAmsterdam Pharma
NAMS
$3.21B
$230K 0.01%
6,566
-939
-13% -$34.2K
CLH icon
419
Clean Harbors
CLH
$16.4B
$227K 0.01%
968
– –
ZG icon
420
Zillow
ZG
$8.19B
$226K 0.01%
3,309
– –
IRTC icon
421
iRhythm Holdings
IRTC
$4.1B
$224K 0.01%
1,264
+127
+11% +$22.5K
UHS icon
422
Universal Health Services
UHS
$10.2B
$224K 0.01%
1,027
+59
+6% +$13K
UBER icon
423
Uber
UBER
$146B
$219K 0.01%
+2,677
New +$241K
KHC icon
424
Kraft Heinz
KHC
$31.3B
$219K 0.01%
+9,017
New +$224K
NWS icon
425
News Corp Class B
NWS
$17.2B
$218K 0.01%
7,352
– –
15 16
17
18 19

Similar funds

SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return

Avanza Fonder's Q4 2025 Portfolio in Review

As of Q4 2025, Avanza Fonder held 529 positions worth $3.94B, up 2.2% from $3.86B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Avanza Fonder's Q4 2025 filing shows 101 new, 162 increased, 70 reduced and 32 closed positions. Its largest new stake was Broadcom: 231,260 shares worth $80M. The largest sale was NVIDIA, an estimated $153M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 39% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Avanza Fonder's largest Q4 2025 buy was Broadcom: 231,260 shares worth $80M.
  • Avanza Fonder added most to Eli Lilly in Q4 2025, an estimated $27.6M increase.
  • Avanza Fonder's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $153M.
  • Avanza Fonder fully exited Healthpeak Properties in Q4 2025, selling an estimated $1.64M.
  • Avanza Fonder's ten largest holdings make up 39% of its $3.94B portfolio in Q4 2025.
  • Avanza Fonder opened 101 new positions and closed 32 in Q4 2025.
  • Avanza Fonder's portfolio value rose 2.2% quarter-over-quarter to $3.94B.

Based on Avanza Fonder's 13F filing for Q4 2025, filed 12 Jan 2026.